Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Moderate COVID- 19 confirmed participants of age > 18 years, both sexes and willing to participate with consent. WHO definition of the moderate case- Pneumonia with no signs of severe disease-Adolescent or adult with the presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2
Exclusion criteria
Exclusion criteria: Those who are not willing to participate, patients with severe co- morbidities such as uncontrolled Diabetes, Liver disease, Renal disorders, uncontrolled Hypertension, pregnant and lactating women and severe COVID-19.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome: Efficacy can be evaluated by a reduction in inflammatory markers and time (No. of days) of reduction of detectable SARS-CoV2 viral RNA in the RT PCR assays from randomization. Secondary outcome: Time from randomization and administration of medicine to recovery is expected to be lesser in the test group Timepoint: Day0 to Day 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| duration of stay in hospitalTimepoint: day 0- day 4 | — |
Countries
India
Contacts
ESIC Medical College and Hospital